— Know what they know.
Not Investment Advice
Also trades as: NUVB-WT (NYSE) · $vol 0M

NUVB NYSE

Nuvation Bio Inc.
1W: +1.5% 1M: -6.5% 3M: -11.9% YTD: -44.2% 1Y: +120.7% 3Y: +199.4% 5Y: -56.5%
$4.72
-0.07 (-1.46%)
 
Weekly Expected Move ±8.7%
$4 $4 $4 $5 $5
NYSE · Healthcare · Biotechnology · Alpha Radar Neutral · Power 40 · $1.6B mcap · 238M float · 1.86% daily turnover · Short 64% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
41.4 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 55.6%
Cost Advantage ★
60
Intangibles
33
Switching Cost
40
Network Effect
47
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. NUVB shows a Weak competitive edge (41.4/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 55.6% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$12
Avg Target
$12
High
Based on 9 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 7Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$12.11
Analysts9
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-01-27 Truist Financial $11 $13 +2 +129.9% $5.66
2026-01-21 RBC Capital Leonid Timashev $5 $12 +7 +99.7% $6.01
2026-01-12 H.C. Wainwright $18 $17 -1 +160.7% $6.52
2026-01-07 UBS Michael Yee Initiated $10 +17.8% $8.49
2025-12-11 H.C. Wainwright $10 $18 +8 +128.3% $7.88
2025-12-01 H.C. Wainwright Robert Burns $7 $10 +3 +24.4% $8.04
2025-11-24 Truist Financial Initiated $11 +57.4% $6.99
2025-11-20 JMP Securities $8 $10 +2 +37.2% $7.29
2025-11-04 JMP Securities $6 $8 +2 +54.7% $5.17
2025-04-23 JMP Securities Silvan Tuerkcan Initiated $6 +188.5% $2.08
2024-09-16 H.C. Wainwright Robert Burns $8 $7 -1 +129.5% $3.05
2024-04-17 RBC Capital Kennen MacKay Initiated $5 +77.9% $2.81
2024-03-28 H.C. Wainwright Robert Burns $14 $8 -6 +101.5% $3.97
2024-03-26 Jefferies Michael Yee $2 $10 +8 +247.2% $2.88
2024-03-26 BTIG Kaveri Pohlman Initiated $5 +122.2% $2.25
2023-01-06 Jefferies Initiated $2 -1.5% $2.03
2022-05-04 H.C. Wainwright Initiated $14 +192.9% $4.78

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
3
ROE
1
ROA
1
D/E
3
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. NUVB receives an overall rating of C. Areas of concern: ROE (1/5), ROA (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-04-28 C- C
2026-04-01 C C-
2026-01-14 C+ C
2026-01-03 C C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

38 Grade D
Profitability
28
Balance Sheet
53
Earnings Quality
62
Growth
88
Value
34
Momentum
80
Safety
15
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. NUVB scores highest in Growth (88/100) and lowest in Safety (15/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
1.19
Distress Zone
Piotroski F-Score
5/9
Beneish M-Score
19.71
Possible Manipulator
Ohlson O-Score
-6.43
Bankruptcy prob: 0.2%
Low Risk
Credit Rating
BB-
Score: 37.1/100
Trend: Improving
Earnings Quality
OCF/NI: 0.86x
Accruals: -3.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. NUVB scores 1.19, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. NUVB scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. NUVB's score of 19.71 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. NUVB's implied 0.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. NUVB receives an estimated rating of BB- (score: 37.1/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-11.23x
PEG
-0.08x
P/S
11.46x
P/B
5.13x
P/FCF
-12.85x
P/OCF
EV/EBITDA
-7.95x
EV/Revenue
7.69x
EV/EBIT
-7.87x
EV/FCF
-8.73x
Earnings Yield
-9.01%
FCF Yield
-7.78%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. NUVB currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.043
EBT / EBIT
×
EBIT Margin
-0.978
EBIT / Rev
×
Asset Turnover
0.252
Rev / Assets
×
Equity Multiplier
1.476
Assets / Equity
=
ROE
-37.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. NUVB's ROE of -37.9% is driven by Asset Turnover (0.252), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1442 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$4.71
Median 1Y
$3.23
5th Pctile
$1.03
95th Pctile
$10.06
Ann. Volatility
71.5%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
David Hung, M.D.
President and Chief Executive Officer
$650,016 $— $3,876,736
Philippe Sauvage Financial
ancial Officer
$510,000 $— $1,478,677
Gary Hattersley, Ph.D.
Chief Scientific Officer
$515,072 $— $1,472,462

CEO Pay Ratio

25505:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $3,876,736
Avg Employee Cost (SGA/emp): $152
Employees: 1,000,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
1,000,000
+454445.5% YoY
Revenue / Employee
$63
Rev: $62,902,000
Profit / Employee
$-205
NI: $-204,627,000
SGA / Employee
$152
Avg labor cost proxy
R&D / Employee
$115
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -29.8% -45.1% -18.1% -18.3% -21.5% -22.6% -14.9% -14.9% -12.9% -11.8% -12.0% -10.9% -81.1% -84.5% -1.1% -1.1% -38.0% -40.7% -53.2% -37.9% -37.94%
ROA -28.9% -43.8% -17.4% -17.6% -20.7% -21.7% -14.4% -14.4% -12.5% -11.4% -11.7% -10.6% -79.0% -82.3% -97.7% -1.0% -34.9% -37.4% -36.0% -25.7% -25.72%
ROIC 78.3% 91.6% 4.5% 4.9% 5.7% 6.0% 56.4% 55.6% 50.1% 48.6% 37.8% 35.4% 203.9% 212.1% 15.6% 16.6% 5.9% 6.1% 78.9% 55.6% 55.61%
ROCE -30.8% -36.0% -12.3% -13.3% -15.6% -16.5% -18.2% -17.9% -15.3% -13.8% -14.4% -12.5% -85.2% -88.7% -1.2% -1.3% -41.9% -44.9% -38.4% -27.3% -27.30%
Gross Margin 6.1% -1.1% 26.2% 32.1% 46.7% 74.5% 99.0% 93.3% 93.25%
Operating Margin -327.8% -66.2% -9.4% -19.1% -13.2% -4.3% -81.3% 4.7% 4.66%
Net Margin -322.3% -56.7% -8.7% -17.3% -12.2% -4.3% -87.4% 6.5% 6.48%
EBITDA Margin -322.0% -56.3% -8.6% -17.1% -12.0% -4.2% -71.5% 5.3% 5.31%
FCF Margin -58.7% -45.9% -16.6% -14.4% -11.7% -7.1% -2.8% -88.1% -88.13%
OCF Margin -58.7% -45.9% -16.6% -14.4% -11.7% -7.1% -2.8% -87.9% -87.90%
ROE 3Y Avg snapshot only -63.29%
ROE 5Y Avg snapshot only -43.52%
ROA 3Y Avg snapshot only -49.26%
ROIC Economic snapshot only -37.90%
Cash ROA snapshot only -21.14%
NOPAT Margin snapshot only -82.94%
Pretax Margin snapshot only -1.02%
R&D / Revenue snapshot only 87.77%
SGA / Revenue snapshot only 1.08%
SBC / Revenue snapshot only 0.82%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -29.66 -27.45 -19.82 -12.79 -6.80 -4.51 -4.03 -3.47 -4.36 -3.54 -4.36 -11.58 -1.40 -1.18 -1.58 -0.98 -3.27 -5.83 -15.08 -11.09 -11.229
P/S Ratio 498.00 289.76 113.84 54.39 46.29 47.36 49.05 11.32 11.456
P/B Ratio 8.83 9.57 2.31 1.50 0.94 0.66 0.64 0.55 0.60 0.45 0.55 1.32 1.18 1.04 1.93 1.28 1.43 2.73 10.09 5.30 5.130
P/FCF -36.05 -35.60 -25.14 -14.29 -7.90 -4.71 -4.35 -4.00 -4.85 -4.24 -4.86 -12.37 -8.48 -6.31 -6.86 -3.78 -3.94 -6.66 -17.75 -12.85 -12.847
P/OCF
EV/EBITDA -25.47 -23.84 -10.30 -3.57 0.51 2.19 1.98 2.49 2.61 4.00 3.16 -2.51 -0.21 -0.04 -0.71 -0.17 -0.85 -3.60 -13.11 -7.95 -7.946
EV/Revenue 74.86 8.91 51.12 9.33 11.89 28.90 40.80 7.69 7.693
EV/EBIT -25.42 -23.79 -10.28 -3.57 0.51 2.19 1.98 2.49 2.61 3.99 3.16 -2.50 -0.21 -0.04 -0.71 -0.17 -0.84 -3.57 -13.03 -7.87 -7.865
EV/FCF -31.95 -31.87 -14.00 -4.58 0.68 2.63 2.46 3.23 3.23 5.25 4.06 -2.95 -1.27 -0.19 -3.08 -0.65 -1.01 -4.06 -14.77 -8.73 -8.730
Earnings Yield -3.4% -3.6% -5.0% -7.8% -14.7% -22.2% -24.8% -28.8% -23.0% -28.2% -22.9% -8.6% -71.5% -85.0% -63.4% -1.0% -30.5% -17.2% -6.6% -9.0% -9.01%
FCF Yield -2.8% -2.8% -4.0% -7.0% -12.7% -21.2% -23.0% -25.0% -20.6% -23.6% -20.6% -8.1% -11.8% -15.9% -14.6% -26.4% -25.4% -15.0% -5.6% -7.8% -7.78%
Price/Tangible Book snapshot only 5.499
EV/Gross Profit snapshot only 8.396
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 33.69 33.69 45.62 45.62 45.62 45.62 50.70 50.70 50.70 50.70 44.11 44.11 44.11 44.11 9.04 9.04 9.04 9.04 6.95 6.95 6.950
Quick Ratio 33.69 33.69 45.62 45.62 45.62 45.62 50.70 50.70 50.70 50.70 44.11 44.11 44.11 44.11 9.04 9.04 9.04 9.04 6.81 6.81 6.811
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.03 0.03 0.033
Net Debt/Equity -1.00 -1.00 -1.02 -1.02 -1.02 -1.02 -1.00 -1.00 -1.00 -1.00 -1.00 -1.00 -1.00 -1.00 -1.06 -1.06 -1.06 -1.06 -1.70 -1.70 -1.698
Debt/Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.017
Debt/EBITDA -0.00 -0.00 -0.03 -0.03 -0.03 -0.02 -0.04 -0.04 -0.04 -0.05 -0.05 -0.05 -0.01 -0.01 -0.02 -0.01 -0.04 -0.04 -0.05 -0.07 -0.073
Net Debt/EBITDA 3.26 2.79 8.19 7.56 6.45 6.11 5.49 5.57 6.53 7.22 6.95 8.02 1.17 1.13 0.87 0.82 2.45 2.30 2.65 3.75 3.748
Interest Coverage -3921.45 -2139.18 -1664.51 -1534.15 -295.63 -203.21 -25.75 -9.78 -9.782
Equity Multiplier 1.03 1.03 1.04 1.04 1.04 1.04 1.03 1.03 1.03 1.03 1.03 1.03 1.03 1.03 1.17 1.17 1.17 1.17 1.95 1.95 1.946
Cash Ratio snapshot only 6.436
Debt Service Coverage snapshot only -9.683
Cash to Debt snapshot only 52.154
FCF to Debt snapshot only -12.423
Defensive Interval snapshot only 711.9 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.02 0.05 0.11 0.25 0.252
Inventory Turnover 1.48 2.10 2.097
Receivables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.46 0.70 0.96 1.33 1.75 3.26 3.92 8.92 8.917
Payables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.62 1.32 1.65 2.14 2.43 2.86 1.07 1.51 1.512
DSO 787 522 381 274 209 112 93 41 40.9 days
DIO 0 0 0 0 0 0 247 174 174.1 days
DPO 589 277 221 170 150 128 342 241 241.4 days
Cash Conversion Cycle 198 245 160 103 59 -16 -2 -26 -26.4 days
Fixed Asset Turnover snapshot only 31.916
Operating Cycle snapshot only 215.0 days
Cash Velocity snapshot only 0.270
Capital Intensity snapshot only 4.158
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 9.0% 11.4% 7.0% 12.1% 12.06%
Net Income -5.8% -2.6% -96.2% -61.2% -44.7% -20.0% -19.3% 12.4% 23.6% 27.3% 34.2% -4.6% -5.4% -6.5% -7.8% 60.3% 59.1% 64.0% 75.9% 75.92%
EPS -6.1% -1.4% -56.0% -51.9% -37.2% -11.2% -16.3% 13.3% 23.8% 27.4% 34.3% -4.1% -4.1% -3.9% -4.7% 71.5% 67.4% 64.7% 78.4% 78.41%
FCF -6.2% -2.3% -1.2% -68.6% -79.6% -40.9% -15.7% 8.5% 33.3% 29.4% 29.1% -3.7% -43.4% -91.8% -1.4% -1.0% -91.5% -33.1% 20.0% 19.98%
EBITDA -5.7% -2.7% -1.2% -78.9% -61.5% -28.3% -16.9% 14.9% 27.1% 26.9% 35.8% -4.1% -4.9% -5.5% -7.0% 61.1% 60.1% 65.5% 77.1% 77.11%
Op. Income -5.7% -2.7% -1.2% -78.9% -61.3% -28.3% -16.9% 10.2% 17.3% 16.6% 20.8% -4.1% -4.4% -4.9% -5.8% 58.2% 58.4% 64.0% 76.2% 76.22%
OCF Growth snapshot only 20.09%
Asset Growth snapshot only 10.02%
Equity Growth snapshot only -34.08%
Debt Growth snapshot only 13.82%
Shares Change snapshot only 11.49%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y
Revenue 5Y
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 77.1% 41.0% 41.0% 41.0% 41.0% -11.4% -11.4% -11.4% -11.4% -4.0% -4.0% -3.99%
Assets 5Y 34.9% 21.8% 21.8% 21.81%
Equity 3Y 77.2% 41.2% 41.2% 41.2% 41.2% -14.7% -14.7% -14.7% -14.7% -22.4% -22.4% -22.43%
Book Value 3Y 76.8% 19.7% 29.6% 32.9% 28.7% -28.0% -26.8% -26.6% -26.5% -33.3% -35.3% -35.33%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.60 0.60 0.60 0.60 0.68 0.46 0.49 0.46 0.459
Earnings Stability 0.97 0.90 0.94 0.43 0.60 0.42 0.20 0.65 0.62 0.58 0.54 0.34 0.45 0.38 0.26 0.258
Margin Stability
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.82 0.92 0.92 0.95 0.91 0.89 0.86 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness
ROE Trend 0.08 -0.04 0.00 0.08 0.12 0.01 0.02 -0.71 -0.74 -1.08 -1.17 0.05 0.03 0.01 0.23 0.233
Gross Margin Trend
FCF Margin Trend
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.82 0.77 0.79 0.89 0.86 0.95 0.92 0.87 0.90 0.83 0.90 0.93 0.16 0.19 0.23 0.26 0.83 0.87 0.85 0.86 0.861
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.003
FCF/Net Income snapshot only 0.863
CapEx/Revenue 4.3% 8.7% 2.1% 1.9% 2.7% 0.9% 0.6% 0.2% 0.23%
CapEx/Depreciation snapshot only 0.231
Accruals Ratio -0.05 -0.10 -0.04 -0.02 -0.03 -0.01 -0.01 -0.02 -0.01 -0.02 -0.01 -0.01 -0.66 -0.67 -0.75 -0.77 -0.06 -0.05 -0.05 -0.04 -0.036
Sloan Accruals snapshot only 0.035
Cash Flow Adequacy snapshot only -381.003
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -0.2% -0.1% 0.0% -0.1% -0.06%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -0.2% -0.1% 0.0% -0.1% -0.06%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 0.97 0.97 0.93 0.87 0.87 0.87 0.87 0.89 0.90 0.91 0.86 0.91 0.99 0.99 1.00 1.00 1.00 1.00 1.04 1.04 1.043
EBIT Margin -360.72 -249.34 -72.09 -55.31 -14.09 -8.09 -3.13 -0.98 -0.978
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.02 0.05 0.11 0.25 0.252
Equity Multiplier 1.03 1.03 1.04 1.04 1.04 1.04 1.03 1.03 1.03 1.03 1.03 1.03 1.03 1.03 1.09 1.09 1.09 1.09 1.48 1.48 1.476
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.31 $-0.36 $-0.43 $-0.41 $-0.48 $-0.50 $-0.48 $-0.48 $-0.41 $-0.38 $-0.35 $-0.31 $-2.09 $-1.95 $-1.69 $-1.79 $-0.60 $-0.64 $-0.59 $-0.39 $-0.39
Book Value/Share $1.05 $1.04 $3.68 $3.50 $3.44 $3.42 $3.00 $2.99 $2.99 $2.99 $2.76 $2.76 $2.47 $2.21 $1.38 $1.37 $1.36 $1.35 $0.89 $0.81 $0.92
Tangible Book/Share $1.05 $1.04 $3.68 $3.50 $3.44 $3.42 $3.00 $2.99 $2.99 $2.99 $2.76 $2.76 $2.47 $2.21 $1.36 $1.36 $1.35 $1.34 $0.86 $0.78 $0.78
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.01 $0.01 $0.02 $0.03 $0.04 $0.08 $0.18 $0.38 $0.41
FCF/Share $-0.26 $-0.28 $-0.34 $-0.37 $-0.41 $-0.48 $-0.44 $-0.42 $-0.37 $-0.32 $-0.31 $-0.29 $-0.34 $-0.36 $-0.39 $-0.47 $-0.49 $-0.56 $-0.50 $-0.33 $-0.36
OCF/Share $-0.26 $-0.28 $-0.34 $-0.37 $-0.41 $-0.47 $-0.44 $-0.41 $-0.37 $-0.32 $-0.31 $-0.29 $-0.34 $-0.36 $-0.39 $-0.46 $-0.49 $-0.55 $-0.50 $-0.33 $-0.36
Cash/Share $1.06 $1.04 $3.78 $3.59 $3.53 $3.51 $3.03 $3.02 $3.02 $3.02 $2.79 $2.79 $2.50 $2.23 $1.49 $1.48 $1.48 $1.47 $1.54 $1.40 $1.54
EBITDA/Share $-0.32 $-0.37 $-0.46 $-0.47 $-0.55 $-0.57 $-0.55 $-0.54 $-0.46 $-0.42 $-0.40 $-0.35 $-2.11 $-1.97 $-1.68 $-1.79 $-0.59 $-0.63 $-0.57 $-0.37 $-0.37
Debt/Share $0.00 $0.00 $0.02 $0.01 $0.01 $0.01 $0.02 $0.02 $0.02 $0.02 $0.02 $0.02 $0.02 $0.01 $0.03 $0.03 $0.03 $0.03 $0.03 $0.03 $0.03
Net Debt/Share $-1.06 $-1.04 $-3.76 $-3.57 $-3.52 $-3.49 $-3.01 $-3.00 $-3.00 $-3.00 $-2.77 $-2.77 $-2.48 $-2.22 $-1.47 $-1.46 $-1.45 $-1.44 $-1.51 $-1.37 $-1.37
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 1.187
Altman Z-Prime snapshot only 3.585
Piotroski F-Score 2 2 3 4 4 4 2 2 3 3 2 2 2 2 2 2 4 4 5 5 5
Beneish M-Score 6.01 17.46 2.13 19.71 19.713
Ohlson O-Score snapshot only -6.434
ROIC (Greenblatt) snapshot only -28.34%
Net-Net WC snapshot only $0.75
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB-
Credit Score 89.00 89.00 74.12 74.77 75.45 75.48 76.78 76.20 76.41 76.48 76.71 76.44 65.62 65.55 50.18 32.67 54.98 65.63 60.98 37.07 37.073
Credit Grade snapshot only 13
Credit Trend snapshot only 4.407
Implied Spread (bps) snapshot only 550.000
Industry Credit Rank snapshot only 29
Sector Credit Rank snapshot only 28

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms